Transcriptomics

Dataset Information

0

Rosiglitazone-induced molecular changes in adipose progenitors


ABSTRACT: White adipose tissue regulates metabolism; the importance of this control is highlighted by the ongoing pandemic of obesity and associated complications such as diabetes, atherosclerosis, and cancer. White adipose tissue maintenance is a dynamic process, very little is known about how pharmacologic stimuli affect such plasticity. Combining in vivo lineage marking and BrdU labeling strategies, we found that rosiglitazone, a member of the thiazolidinedione class of glucose-lowering medicines, markedly increases the evolution of adipose progenitors into adipocytes. Notably, chronic rosiglitazone administration disrupts the adipogenic and self-renewal capacities of the stem cell compartment and alters its molecular characteristics. These data unravel unknown aspects of adipose dynamics and provide a basis to manipulate the adipose lineage for therapeutic ends. The goal of this gene expression array was to identify changes in molecular expression in adipose progenitors isolated from mice that underwent two-month rosiglitazone treatment.

ORGANISM(S): Mus musculus

PROVIDER: GSE30116 | GEO | 2012/01/18

SECONDARY ACCESSION(S): PRJNA143869

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-01-18 | E-GEOD-30116 | biostudies-arrayexpress
2010-06-25 | GSE22553 | GEO
2007-02-17 | GSE7027 | GEO
2010-07-29 | E-GEOD-22553 | biostudies-arrayexpress
2020-06-01 | GSE115221 | GEO
2017-06-05 | ST000675 | MetabolomicsWorkbench
2017-02-07 | GSE93402 | GEO
2017-02-07 | GSE93403 | GEO
2017-02-07 | GSE93406 | GEO
2020-02-26 | GSE117198 | GEO